Evidence map›Paper›PMID 42367240›Full record

ArticleJournal of translational autoimmunity2026

The clinical profile of systemic sclerosis without a 'scleroderma pattern' at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology.

Antonio Tonutti, Maria De Santis, Francesca Motta, Gianluigi Bajocchi, Dilia Giuggioli, Silvia Bellando-Randone, Cosimo Bruni, Giovanni Zanframundo, Roberta Foti, Giovanna Cuomo and 63 more

Abstract read
In one paragraph

Article in Journal of translational autoimmunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

73 authors.

Antonio TonuttiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, 20072, Italy.
Maria De SantisDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, 20072, Italy.
Francesca MottaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, 20072, Italy.
Gianluigi BajocchiRheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Dilia GiuggioliRheumatology Unit, School of Medicine, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
Silvia Bellando-RandoneDivision of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, Florence, Italy.
Cosimo BruniDivision of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, Florence, Italy.
Giovanni ZanframundoDepartment of Rheumatology, Policlinico San Matteo, Pavia, Italy.
Roberta FotiRheumatology Unit, A.O.U Policlinico S. Marco, Catania, Italy.
Giovanna CuomoDepartment of Precision Medicine - University of Campania "Luigi Vanvitelli", Naples, Caserta, Italy.
Alarico ArianiDepartment of Medicine, Internal Medicine and Rheumatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Edoardo RosatoDepartment of Translational and Precision Medicine, Sapienza University of Rome, Italy, Roma, Italy.
Gemma LepriDivision of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, Florence, Italy.
Francesco GirelliDepartment of Medicine, Rheumatology Unit, Ospedale Morgagni - Pierantoni, Forlì, Italy.
Elisabetta ZanattaDepartment of Rheumatology, University of Padua, Padua, Italy.
Silvia Laura BoselloDivision of Rheumatology and Clinical Immunology, Fondazione Policlinico Universitario A. Gemelli-IRCCS and Catholic University of the Sacred Heart, Rome, Italy.
Ilaria CavazzanaRheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Francesca IngegnoliRheumatology Clinic, Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO, Department of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano, Milan, Italy.
Fabio CacciapagliaDepartment of Medicine and Surgery, LUM University "Giuseppe Degennaro" Casamassima - Rheumatology Unit "F. Miulli" General Hospital Acquaviva delle Fonti, Bari, Italy.
Giuseppe MurdacaResearch Hospital San Martino, University of Genoa, Genoa, Italy.
Giuseppina AbignanoRheumatology Institute of Lucania (IReL), San Carlo Hospital, Potenza and University of Basilicata, Department of Health of Science, Potenza, Italy.
Giorgio PettitiAzienda Ospedaliera S. Croce e Carle, Cuneo, Italy.
Alessandra Della RossaDepartment of Rheumatology, University of Pisa, Pisa, Italy.
Maurizio CaminitiDepartmental Rheumatology Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
Anna Maria IulianoRheumatology Unit, San Camillo - Forlanini Hospital, Rome, Italy.
Giovanni CianoHospital of Ariano Irpino, Local Health Department, Ariano Irpino, Avellino, Italy.
Lorenzo BerettaReferral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico di Milano, Milan, Italy.
Gianluca BagnatoDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Ennio LubranoDepartment of Rheumatology, University of Molise, Campobasso, Italy.
Ilenia De AndresRheumatology Unit, Azienda Ospedaliera di Rilievo Nazionale ed Alta Specializzazione "Garibaldi", Catania, Italy.
Luca IdolazziRheumatology Section, Department of Medicine, University of Verona, Verona, Italy.
Marta SaraccoRheumatology Unit, Mauriziano-Umberto I Hospital, Turin, Italy.
Cecilia AgnesDepartment of Medicine, San Lorenzo Hospital, Carmagnola, Turin, Italy.
Corrado CampochiaroUnit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS Ospedale San Raffaele, Milan, Italy.
Giacomo De LucaUnit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS Ospedale San Raffaele, Milan, Italy.
Martina OrlandiRheumatology Unit, School of Medicine, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
Marco Di BattistaDepartment of Rheumatology, University of Pisa, Pisa, Italy.
Mariangela NivuoriUnit of Rheumatology, Department of Precision and Regenerative Medicine, Area Jonica (DiMePRe-J) University of Bari, Italy.
Livio MilazzoRheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.
Edoardo CipollettaDepartment of Internal Medicine, Marche University Hospital, Ancona, Italy.
Federica LumettiRheumatology Unit, School of Medicine, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
Amelia SpinellaRheumatology Unit, School of Medicine, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
Emanuele CocchiaraRheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Veronica CodulloDepartment of Rheumatology, Policlinico San Matteo, Pavia, Italy.
Beatrice MoccaldiDepartment of Rheumatology, University of Padua, Padua, Italy.
Elisa VisalliRheumatology Unit, A.O.U Policlinico S. Marco, Catania, Italy.
Carlo IandoliDepartment of Precision Medicine - University of Campania "Luigi Vanvitelli", Naples, Caserta, Italy.
Antonietta GiganteDepartment of Translational and Precision Medicine, Sapienza University of Rome, Italy, Roma, Italy.
Greta PellegrinoIRCCS Ospedale Galeazzi Sant'Ambrogio, Milan, Italy.
Erika PigattoUOC Medicina Generale, Azienda Pedemontana 7, San Bassiano Hospital, Bassano del Grappa, Italy.
Maria Grazia LazzaroniRheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Enrico De LorenzisDivision of Rheumatology and Clinical Immunology, Fondazione Policlinico Universitario A. Gemelli-IRCCS and Catholic University of the Sacred Heart, Rome, Italy.
Gianna MennilloRheumatology Institute of Lucania (IReL), San Carlo Hospital, Potenza and University of Basilicata, Department of Health of Science, Potenza, Italy.
Giuseppa Pagano-MarianoDepartmental Rheumatology Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
Federica FuriniRheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria S. Anna, Ferrara, Italy.
Licia VultaggioRheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria S. Anna, Ferrara, Italy.
Simone ParisiRheumatology Unit, Città della Salute e della Scienza, Turin, Italy.
Clara Lisa PeroniRheumatology Unit, Città della Salute e della Scienza, Turin, Italy.
Enrico FusaroRheumatology Unit, Città della Salute e della Scienza, Turin, Italy.
Gerolamo BianchiRheumatology Unit, Department of Musculoskeletal Sciences, Local Health Trust La Colletta Hospital, Genoa, Italy.
Gian Domenico SebastianiRheumatology Unit, San Camillo - Forlanini Hospital, Rome, Italy.
Marcello GovoniRheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria S. Anna, Ferrara, Italy.
Salvatore D'AngeloRheumatology Institute of Lucania (IReL), San Carlo Hospital, Potenza and University of Basilicata, Department of Health of Science, Potenza, Italy.
Franco CozziDepartment of Medicine, Villa Salus Hospital, Venice, Italy.
Franco FranceschiniRheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Serena GuiducciDivision of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, Florence, Italy.
Valeria RiccieriDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Lorenzo DagnaUnit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS Ospedale San Raffaele, Milan, Italy.
Carlo SalvaraniRheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Florenzo IannoneUnit of Rheumatology, Department of Precision and Regenerative Medicine, Area Jonica (DiMePRe-J) University of Bari, Italy.
Marco Matucci-CerinicUnit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS Ospedale San Raffaele, Milan, Italy.
Clodoveo FerriRheumatology Unit, School of Medicine, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
Rossella De AngelisRheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Microvascular alterations can be detected with nailfold videocapillaroscopy, useful for systemic sclerosis (SSc) diagnosis upon identification of the "scleroderma pattern" (NVC-SP). However, this pattern is missing in a subset of SSc patients. Methods: This retrospective analysis on the multicenter Italian SPRING cohort of SSc patients assessed the prevalence and characteristics of patients without NVC-SP. Associations with demographic and clinical features were evaluated using logistic regression (cross-sectional) and mixed-effects models (longitudinal). Results: Out of 1689 SSc patients with available NVC information, 90 (5.3%) did not have the NVC-SP. These patients were older at SSc onset (53 vs. 49 years) and more frequently sine scleroderma (31% vs 12%, p < 0.001). The overall burden of vascular complications was milder in this subset, with a lower prevalence of pitting scars (33% vs 48%), telangiectasias (52% vs 74%), and calcinosis (3.4% vs 12%). During the follow-up, mRSS remained lower (60-month mean 4 vs 7, p = 0.002), as well as the estimated probability of vascular complications. Moreover, despite comparable values at baseline, DLCO remained significantly higher in patients without NVC-SP at the following time points (12, 24, and 60 months, p < 0.05). The presence of "late" NVC-SP was independently associated with ILD (OR 1.83, 95% CI 1.05-3.18). Conclusions: The absence of NVC-SP in 5.3% of SPRING SSc patients may identify a subset characterized by milder disease, with a lower burden of vascular and organ complications. Conversely, lung involvement was more frequently observed in patients with more severe NVC microangiopathy.

Indexed as

Nailfold capillaroscopyPhenotypeScleroderma patternSystemic sclerosis

Identifiers

PMID42367240
PMCPMC13293697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.